LTI-291 |
| Catalog No.GC19226 |
LTI-291 es un activador de glucocerebrosidasa (Gcase) extraÍdo de la patente WO 2017192841 A1.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1919820-28-2
Sample solution is provided at 25 µL, 10mM.
;)
,-1-7$$$37316672.jpg');)
;)
;)
$$$36806353.jpg');)
;33(7)%EF%BC%9A546-561$$$37156877.jpg');)
;)
;)
;)
%201124-1138.$$$35908550.jpg');)
%20766-780.$$$37100057.jpg');)
%20418-432.$$$36893736.jpg');)
%EF%BC%9A-240-255.$$$35108512.jpg');)
533-545$$$36543525.jpg');)
%201-13.$$$36600053.jpg');)
;)
LTI-291 is an activator of glucocerebrosidase (Gcase) extracted from patent WO 2017192841 A1.
References:
[1]. Renato T. Skerlj, et al. Methods of treatment and combination therapies using gcase activator heterobicyclic and related compounds. WO 2017192841 A1.
Review for LTI-291
Average Rating: 5 (Based on Reviews and 40 reference(s) in Google Scholar.)
Review for LTI-291
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *